Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b: H4 and O16: H5 ST131 strains

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 5, 2014, Pages 1231-1237

  Blanc, Véronique ^a   Leflon Guibout, Véronique ^b   Blanco, Jorge ^c   Haenni, Marisa ^a   Madec, Jean Yves ^a   Rafignon, Gwenaele ^b   Bruno, Pascale ^d   Mora, Azucena ^c   Lopez, Cecilia ^c   Dahbi, Ghizlane ^c   Dunais, Brigitte ^d   Anastay, Magali ^a   Branger, Catherine ^a   Moreau, Richard ^e   Pradier, Christian ^d   Nicolas Chanoine, Marie Helene ^a,b,e  

^a Service de Biologie Centre Hospitalier d'Antibes Juan les Pins ^*  (France)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e INSERM   (France)

Author keywords

E. coli; FimH based subclones; Plasmids; Virotypes

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; LEVOFLOXACIN; NITROFURANTOIN; BETA LACTAMASE;

AGAR MEDIUM; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAY CARE; DIGESTIVE SYSTEM; ESCHERICHIA COLI; FECES; FRANCE; GENOTYPE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; CLASSIFICATION; CLUSTER ANALYSIS; ENZYMOLOGY; EPIDEMIOLOGY; ESCHERICHIA COLI INFECTION; FEMALE; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHYLOGENY; PRESCHOOL CHILD; SECRETION (PROCESS); SEROTYPING;

BETA-LACTAMASES; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; FRANCE; GENOTYPE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHYLOGENY; PREVALENCE; SEROTYPING;

EID: 84899568769     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt519     Document Type: Article

References (54)

1. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-75.
2. Pitout JD. Infections with ESBL-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70: 313-33.
3. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
4. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
5. Brisse S, Diancourt L, Laouenan C et al. Phylogenetic distribution of CTX-M-and non-extended-spectrum β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol 2012; 50: 2974-81.
6. Gibreel TM, Dodgson AR, Cheesbrough J et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from north-west England. J Antimicrob Chemother 2012; 67: 346-56.
7. Chandramohan L, Revell PA. Prevalence and molecular characterization of extended-spectrumβ-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother 2012; 56: 4765-70.
8. Kudinha T, Johnson JR, Andrew SD et al. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr Infect Dis J 2013; 32: 543-8.
9. Ben Sallem R, Ben Slama K, Estepa V et al. Prevalence and characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 1511-6.
10. Geser N, Stephan R, Korczak BM et al. Molecular identification of blaESBL genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2011; 74: 446-9.
11. Luvsansharav UO, Hirai I, Niki M et al. Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011; 17: 722-5.
12. Nicolas-Chanoine M-H, Gruson C, Bialek-Davenet S et al. 10-Fold increase (2006-11) in the rate of healthy subjects with extendedspectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 2013; 68: 562-8.
13. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007; 28: 1114-6.
14. Li B, Sun JY, Liu QZ et al. High prevalence of CTX-M β-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 2011; 43: 170-4.
15. Luvsansharav UO, Hirai I, Niki M et al. Analysis of risk factors for a high prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand.JMedMicrobiol 2011; 60: 619-24.
16. Pallecchi L, Bartoloni A, Fiorelli C et al. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007; 51: 2720-5.
17. Kaarme J, Molin Y, Olsen B et al. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy Swedish preschool children. Acta Paediatr 2013; 102: 655-60.
18. Boutet-Dubois A, Pantel A, Prere MF et al. Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France. Eur J Clin Microbiol Infect Dis 2013; 32: 1063-8.
19. Birgy A, Cohen R, Levy C et al. Community faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in French children. BMC Infect Dis 2012; 12: 315.
20. Jarlier V, Nicolas MH, Fournier G et al. Extended-broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-78.
21. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-42.
22. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
23. Blanco J, Mora A, Mamani R et al. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J Clin Microbiol 2013; 51: 3358-67.
24. Weissman SJ, Johnson JR, Tchesnokova V et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012; 78: 1353-60.
25. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
26. Caratolli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
27. Garcia-Fernandez A, Chiaretto G, Bertini A et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum β-lactamases in Escherichia coli and Salmonella of human and animal origin. J Antimicrob Chemother 2008; 61: 1229-33.
28. Villa L, Garcia-Fernandez A, Fortini D et al. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65: 2518-29.
29. Canton R, Novais A, Valverde A et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 Suppl 1: 144-53.
30. Rodriguez-Bano J, Lopez-Cerero L, Navarro MD et al. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008; 62: 1142-9.
31. Löhr IH, Rettedal S, Natas OB et al. Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak. J Antimicrob Chemother 2013; 68: 1043-8.
32. Birgy A, Mariani-Kurkdjian P, Bidet P et al. Characterization of extended-spectrum β-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. J Clin Microbiol 2013; 51: 1727-32.
33. Weissman SJ, Adler A, Qin X et al. Emergence of extended-spectrum β-lactam resistance among Escherichia coli at a US academic children's hospital is clonal at the sequence type level for CTX-M-15, but not for CMY-2. Int J Antimicrob Agents 2013; 41: 414-20.
34. Dahbi G, Mora A, Lopez C et al. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. Int J Antimicrob Agents 2013; 42: 347-51.
35. Matsumura Y, Yamamoto M, Nagao M et al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum β-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 2012; 67: 2612-20.
36. Olesen B, Hansen DS, Nilsson F et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum β-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013; 51: 1779-85.
37. Platell JL, Cobbold RN, Johnson JR et al. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia. Antimicrob Agents Chemother 2011; 55: 3782-7.
38. Johnson JR, Tchesnokova V, Johnston B et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207: 919-28.
39. Matsumura Y, Yamamoto M, Nagao M et al. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups. Antimicrob Agents Chemother 2013; 57: 4736-42.
40. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
41. Jouini A, Slama KB, Klibi N et al. Lineages and virulence gene content among extended-spectrum β-lactamase-producing Escherichia coli strains of food origin in Tunisia. J Food Prot 2013; 76: 323-7.
42. Castanheira M, Deshpande LM, Farell SM et al. Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. Diagn Microbiol Infect Dis 2013; 75: 210-3.
43. Koo HJ, Kwak HS, Yoon SH et al. Phylogenetic group distribution and prevalence of virulence genes in Escherichia coli isolates from food samples in South Korea. World J Microbiol Biotechnol 2012; 28: 1813-6.
44. Mora A, Blanco M, López C et al. Emergence of clonal groups O1:HNM-DST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 2011; 37: 16-21.
45. Dahmen S, Metayer V, Gay E et al. Characterization of extendedspectrum β-lactamase (ESBL)-carrying plasmids and clones of Enterobacteriaceae causing cattle mastitis in France. Vet Microbiol 2013; 162: 793-9.
46. Chen Y, Chen X, Zheng S et al. Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China. Clin Microbiol Infect 2014; 20: 52-8.
47. Dimou V, Dhanji H, Pike R et al. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 2012; 67: 1660-5.
48. Dobiasova H, Dolejska M, Jamborova I et al. Extended spectrum β-lactamase and fluoroquinolone resistance genes and plasmids among Escherichia coli isolates from zoo animals, Czech Republic. FEMS Microbiol Ecol 2013; 85: 604-11.
49. Osterblad M, Kirveskari J, Hakanen AJ et al. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother 2012; 67: 2860-4.
50. Peirano G, Hung King Sang J, Pitondo-Silva A et al. Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J Antimicrob Chemother 2012; 67: 1114-20.
51. Usui M, Iwasa T, Fukuda A et al. The role of flies in spreading the extended-spectrum β-lactamase gene from cattle. Microb Drug Resist 2013; 19: 415-20.
52. Cremet L, Caroff N, Giraudeau C et al. Detection of clonally related Escherichia coli isolates producing different CMY β-lactamases from a cystic fibrosis patient. J Antimicrob Chemother 2013; 68: 1032-5.
53. Lopez-Cerero L, Bellido M, Serrano L et al. Comparative analysis of Inc F plasmids from different lineages of ST131 Escherichia coli carrying or not extended-spectrum β-lactamases (ESBL) from southern Spain. In: Abstracts of the Twenty-third European Congress of Clinical Microbiology and Infectious Diseases, Berlin, 2013. Abstract P1213. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
54. Dhanji H, Doumith M, Rooney PJ et al. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum β-lactamases in nursing homes in Belfast, UK. J Antimicrob Chemother 2011; 66: 297-303.